vs

Side-by-side financial comparison of BioAge Labs, Inc. (BIOA) and SemiLEDs Corp (LEDS). Click either name above to swap in a different company.

BioAge Labs, Inc. is the larger business by last-quarter revenue ($3.1M vs $2.6M, roughly 1.2× SemiLEDs Corp). SemiLEDs Corp runs the higher net margin — -28.9% vs -842.9%, a 814.0% gap on every dollar of revenue. SemiLEDs Corp produced more free cash flow last quarter ($331.0K vs $-28.4M).

Altos Labs, Inc. is an American biotechnology research company. Altos Labs' goal is to develop life extension therapies that can halt or reverse the human aging process. Specialized cell therapies based on induced pluripotent stem cells are to be developed for this purpose. Russian-born technology businessman Yuri Milner, along with investors including Jeff Bezos, funded the company in 2021, operations started in 2022.

SEMI is an industry association comprising companies involved in the electronics design and manufacturing supply chain. They provide equipment, materials and services for the manufacture of semiconductors, photovoltaic panels, LED and flat panel displays, micro-electromechanical systems (MEMS), printed and flexible electronics, and related micro and nano-technologies.

BIOA vs LEDS — Head-to-Head

Bigger by revenue
BIOA
BIOA
1.2× larger
BIOA
$3.1M
$2.6M
LEDS
Higher net margin
LEDS
LEDS
814.0% more per $
LEDS
-28.9%
-842.9%
BIOA
More free cash flow
LEDS
LEDS
$28.7M more FCF
LEDS
$331.0K
$-28.4M
BIOA

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
BIOA
BIOA
LEDS
LEDS
Revenue
$3.1M
$2.6M
Net Profit
$-25.9M
$-742.0K
Gross Margin
0.7%
Operating Margin
-923.4%
-39.4%
Net Margin
-842.9%
-28.9%
Revenue YoY
103.7%
Net Profit YoY
-35.6%
EPS (diluted)
$-0.72
$-0.09

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BIOA
BIOA
LEDS
LEDS
Q4 25
$3.1M
$2.6M
Q3 25
$2.1M
$13.2M
Q2 25
$2.4M
$17.7M
Q1 25
$1.5M
$10.9M
Q4 24
$1.3M
Q3 24
$0
$1.3M
Q2 24
$1.3M
Q1 24
$886.0K
Net Profit
BIOA
BIOA
LEDS
LEDS
Q4 25
$-25.9M
$-742.0K
Q3 25
$-20.2M
$-1.2M
Q2 25
$-21.6M
$223.0K
Q1 25
$-12.9M
$388.0K
Q4 24
$-547.0K
Q3 24
$-23.4M
Q2 24
$-319.0K
Q1 24
$-559.0K
Gross Margin
BIOA
BIOA
LEDS
LEDS
Q4 25
0.7%
Q3 25
1.7%
Q2 25
5.3%
Q1 25
9.2%
Q4 24
20.6%
Q3 24
11.6%
Q2 24
41.0%
Q1 24
12.6%
Operating Margin
BIOA
BIOA
LEDS
LEDS
Q4 25
-923.4%
-39.4%
Q3 25
-1126.6%
-9.0%
Q2 25
-1027.0%
-0.4%
Q1 25
-1133.4%
1.0%
Q4 24
-52.1%
Q3 24
Q2 24
-35.8%
Q1 24
-93.9%
Net Margin
BIOA
BIOA
LEDS
LEDS
Q4 25
-842.9%
-28.9%
Q3 25
-982.0%
-9.0%
Q2 25
-894.0%
1.3%
Q1 25
-891.0%
3.6%
Q4 24
-43.4%
Q3 24
Q2 24
-24.1%
Q1 24
-63.1%
EPS (diluted)
BIOA
BIOA
LEDS
LEDS
Q4 25
$-0.72
$-0.09
Q3 25
$-0.56
$-0.15
Q2 25
$-0.60
$0.03
Q1 25
$-0.36
$0.05
Q4 24
$-0.08
Q3 24
$-6.70
Q2 24
$-0.04
Q1 24
$-0.11

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BIOA
BIOA
LEDS
LEDS
Cash + ST InvestmentsLiquidity on hand
$281.1M
$2.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$272.1M
$2.1M
Total Assets
$294.9M
$14.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BIOA
BIOA
LEDS
LEDS
Q4 25
$281.1M
$2.9M
Q3 25
$285.8M
$2.6M
Q2 25
$297.3M
$2.4M
Q1 25
$320.5M
$2.4M
Q4 24
$1.2M
Q3 24
$334.5M
$1.7M
Q2 24
$1.7M
Q1 24
$1.6M
Total Debt
BIOA
BIOA
LEDS
LEDS
Q4 25
Q3 25
$1.7M
Q2 25
Q1 25
$7.1M
Q4 24
Q3 24
$9.9M
$3.7M
Q2 24
Q1 24
Stockholders' Equity
BIOA
BIOA
LEDS
LEDS
Q4 25
$272.1M
$2.1M
Q3 25
$277.5M
$2.8M
Q2 25
$294.8M
$4.0M
Q1 25
$313.2M
$3.6M
Q4 24
$1.6M
Q3 24
$313.7M
$2.2M
Q2 24
$2.7M
Q1 24
$3.0M
Total Assets
BIOA
BIOA
LEDS
LEDS
Q4 25
$294.9M
$14.2M
Q3 25
$305.1M
$15.6M
Q2 25
$322.1M
$23.2M
Q1 25
$343.8M
$23.2M
Q4 24
$10.4M
Q3 24
$337.4M
$11.1M
Q2 24
$11.5M
Q1 24
$12.0M
Debt / Equity
BIOA
BIOA
LEDS
LEDS
Q4 25
Q3 25
0.61×
Q2 25
Q1 25
0.02×
Q4 24
Q3 24
0.03×
1.69×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BIOA
BIOA
LEDS
LEDS
Operating Cash FlowLast quarter
$-28.3M
$361.0K
Free Cash FlowOCF − Capex
$-28.4M
$331.0K
FCF MarginFCF / Revenue
-921.5%
12.9%
Capex IntensityCapex / Revenue
3.6%
1.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-82.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BIOA
BIOA
LEDS
LEDS
Q4 25
$-28.3M
$361.0K
Q3 25
$-16.0M
Q2 25
$-20.0M
$693.0K
Q1 25
$-17.4M
$1.4M
Q4 24
$-158.0K
Q3 24
Q2 24
$109.0K
Q1 24
$-600.0K
Free Cash Flow
BIOA
BIOA
LEDS
LEDS
Q4 25
$-28.4M
$331.0K
Q3 25
$-16.1M
Q2 25
$-20.1M
$383.0K
Q1 25
$-17.8M
$1.3M
Q4 24
$-276.0K
Q3 24
Q2 24
$98.0K
Q1 24
$-619.0K
FCF Margin
BIOA
BIOA
LEDS
LEDS
Q4 25
-921.5%
12.9%
Q3 25
-782.2%
Q2 25
-834.5%
2.2%
Q1 25
-1226.0%
11.8%
Q4 24
-21.9%
Q3 24
Q2 24
7.4%
Q1 24
-69.9%
Capex Intensity
BIOA
BIOA
LEDS
LEDS
Q4 25
3.6%
1.2%
Q3 25
1.1%
0.2%
Q2 25
6.6%
1.8%
Q1 25
29.4%
1.1%
Q4 24
9.4%
Q3 24
9.3%
Q2 24
0.8%
Q1 24
2.1%
Cash Conversion
BIOA
BIOA
LEDS
LEDS
Q4 25
Q3 25
Q2 25
3.11×
Q1 25
3.62×
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons